Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Insulin9623 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A10330 | 31387054 | Phytomedicine | The combination of Ilexhainanoside D and ilexsaponin A1 reduces liver inflammation and improves intestinal barrier function in mice with high-fat diet-induced non-alcoholic fatty liver disease. | 2019 | Details |
| A10332 | 31386565 | Am J Physiol Endocrinol Metab | Adipocyte-specific deletion of IL-6 does not attenuate obesity-induced weight gain or glucose intolerance in mice. | 2019 | Details |
| A10337 | 31384535 | Acta Pharm Sin B | Silibinin ameliorates hepatic lipid accumulation and oxidative stress in mice with non-alcoholic steatohepatitis by regulating CFLAR-JNK pathway. | 2019 | Details |
| A10338 | 31384531 | Acta Pharm Sin B | Ablation of gut microbiota alleviates obesity-induced hepatic steatosis and glucose intolerance by modulating bile acid metabolism in hamsters. | 2019 | Details |
| A10339 | 31384519 | Biosci Microbiota Food Health | The role of gut microbiota in non-alcoholic fatty liver disease: pathways of mechanisms. | 2019 | Details |
| A10341 | 31383290 | Tissue Cell | Azoramide ameliorates fructose-induced nonalcoholic fatty liver disease in mice. | 2019 | Details |
| A10343 | 31381969 | J Steroid Biochem Mol Biol | Understanding the association of polycystic ovary syndrome and non-alcoholic fatty liver disease. | 2019 | Details |
| A10360 | 31375010 | Int J Environ Res Public Health | Novel Insights into the Genetic Landscape of Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A10365 | 31373184 | J Korean Med Sci | Non-Alcoholic Fatty Liver Disease and Its Association with Depression in Korean General Population. | 2019 | Details |
| A10367 | 31372694 | Naunyn Schmiedebergs Arch Pharmacol | Chrysin ameliorates nonalcoholic fatty liver disease in rats. | 2019 | Details |
| A10369 | 31372020 | Diabetes Metab Syndr Obes | Abdominal subcutaneous fat thickness and homeostasis model assessment of insulin resistance as simple predictors of nonalcoholic steatohepatitis. | 2019 | Details |
| A10370 | 31371265 | Nutr Metab Cardiovasc Dis | Non-invasive assessment of hepatic lipid subspecies matched with non-alcoholic fatty liver disease phenotype. | 2019 | Details |
| A10377 | 31366455 | Gut | Epidemiology of chronic liver diseases in the USA in the past three decades. | 2019 | Details |
| A10379 | 31364723 | Int J Mol Med | Green tea polyphenols attenuate hepatic steatosis, and reduce insulin resistance and inflammation in high-fat diet-induced rats. | 2019 | Details |
| A10392 | 31357780 | Zhonghua Gan Zang Bing Za Zhi | [A new attempt with lipoprotein lipase agonists in the treatment of nonalcoholic steatohepatitis]. | 2019 | Details |
| A10400 | 31354322 | Diabetes Metab Syndr Obes | Obesity, adipocyte hypertrophy, fasting glucose, and resistin are potential contributors to nonalcoholic fatty liver disease in South Asian women. | 2019 | Details |
| A10401 | 31353974 | Expert Rev Gastroenterol Hepatol | Concurrent nonalcoholic fatty liver disease and type 2 diabetes: diagnostic and therapeutic considerations. | 2019 | Details |
| A10414 | 31345776 | Lancet Diabetes Endocrinol | Risk of diabetes-associated diseases in subgroups of patients with recent-onset diabetes: a 5-year follow-up study. | 2019 | Details |
| A10419 | 31343128 | Pediatr Endocrinol Diabetes Metab | Usefulness of the metabolic syndrome diagnosis in obese children in clinical practice. | 2019 | Details |
| A10421 | 31343010 | Food Funct | Oral α-lipoic acid supplementation in patients with non-alcoholic fatty liver disease: effects on adipokines and liver histology features. | 2019 | Details |
| A10425 | 31341532 | Oxid Med Cell Longev | Dietary Glycotoxins Impair Hepatic Lipidemic Profile in Diet-Induced Obese Rats Causing Hepatic Oxidative Stress and Insulin Resistance. | 2019 | Details |
| A10426 | 31341444 | Integr Med (Encinitas) | Non-Alcoholic Fatty Liver Disease, an Overview. | 2019 | Details |
| A10429 | 31340202 | J Endocrinol | Prenatal caffeine exposure induces liver developmental dysfunction in offspring rats. | 2019 | Details |
| A10432 | 31338065 | Front Endocrinol (Lausanne) | Resveratrol Reduces Glucolipid Metabolic Dysfunction and Learning and Memory Impairment in a NAFLD Rat Model: Involvement in Regulating the Imbalance of Nesfatin-1 Abundance and Copine 6 Expression. | 2019 | Details |
| A10438 | 31336502 | Diabetes Metab Syndr | The influence of insulin resistance in the occurence of non-alcoholic fatty liver disease among first degree relatives of type 2 diabetes. | 2019 | Details |
| A10439 | 31336476 | Diabetes Metab Syndr | Nutrition and physical activity in Asian Indians with non-alcoholic fatty liver: A case control study. | 2019 | Details |
| A10440 | 31336445 | Diabetes Metab Syndr | Insulin resistance and hyperandrogenemia independently predict nonalcoholic fatty liver disease in women with polycystic ovary syndrome. | 2019 | Details |
| A10442 | 31336149 | Biochim Biophys Acta Mol Basis Dis | The adipokine sFRP4 induces insulin resistance and lipogenesis in the liver. | 2019 | Details |
| A10446 | 31334442 | Hepatol Commun | Insulin Resistance Exacerbates Genetic Predisposition to Nonalcoholic Fatty Liver Disease in Individuals Without Diabetes. | 2019 | Details |
| A10448 | 31333877 | Clin Diabetes Endocrinol | Natural history of ROHHAD syndrome: development of severe insulin resistance and fatty liver disease over time. | 2019 | Details |
| A10456 | 31330134 | Metabolism | AKR1D1 is a novel regulator of metabolic phenotype in human hepatocytes and is dysregulated in non-alcoholic fatty liver disease. | 2019 | Details |
| A10458 | 31328113 | Prev Nutr Food Sci | Health Benefits of Carotenoids: A Role of Carotenoids in the Prevention of Non-Alcoholic Fatty Liver Disease. | 2019 | Details |
| A10459 | 31328066 | Cureus | A Retrospective Study to Examine the Correlation of Bioelectrical Impedance Analysis with Shear-wave Elastography in Indian Patients with Non-alcoholic Fatty Liver Disease and Diabetes on Background Sodium-glucose Cotransporter-2 Inhibitor Therapy. | 2019 | Details |
| A10463 | 31325892 | J Nutr Biochem | Apigenin ameliorates HFD-induced NAFLD through regulation of the XO/NLRP3 pathways. | 2019 | Details |
| A10465 | 31325638 | Biochim Biophys Acta Mol Cell Biol Lipids | Ursodeoxycholic acid is a GPBAR1 agonist and resets liver/intestinal FXR signaling in a model of diet-induced dysbiosis and NASH. | 2019 | Details |
| A10470 | 31324087 | J Assoc Physicians India | Effects of Canagliflozin on Abnormal Liver Function Tests in Patients of Type 2 Diabetes with Non-Alcoholic Fatty Liver Disease. | 2018 | Details |
| A10481 | 31318914 | PLoS One | Hepatic enzyme ALT as a marker of glucose abnormality in men with cystic fibrosis. | 2019 | Details |
| A10485 | 31316594 | Exp Ther Med | Effect of resveratrol on non-alcoholic fatty liver disease. | 2019 | Details |
| A10486 | 31315613 | BMC Endocr Disord | The relationship between non-alcoholic fatty liver and skeletal muscle mass to visceral fat area ratio in women with type 2 diabetes. | 2019 | Details |
| A10495 | 31311491 | BMC Gastroenterol | Low vitamin D level was associated with metabolic syndrome and high leptin level in subjects with nonalcoholic fatty liver disease: a community-based study. | 2019 | Details |
| A10507 | 31308717 | Diabetes Metab Syndr Obes | Liraglutide ameliorates nonalcoholic fatty liver disease in diabetic mice via the IRS2/PI3K/Akt signaling pathway. | 2019 | Details |
| A10508 | 31308716 | Diabetes Metab Syndr Obes | SGLT-2 inhibitors as promising therapeutics for non-alcoholic fatty liver disease: pathophysiology, clinical outcomes, and future directions. | 2019 | Details |
| A10511 | 31308382 | Sci Rep | Natural course of fatty liver in 36,195 South Korean adults. | 2019 | Details |
| A10519 | 31305201 | Metab Syndr Relat Disord | The Effect of Low Glycemic Index and Glycemic Load Diets on Hepatic Fat Mass, Insulin Resistance, and Blood Lipid Panels in Individuals with Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A10520 | 31304703 | J Assoc Physicians India | Association of Genetic Non-alcoholic Fatty Liver Disease with Insulin Resistance-Are we Different? | 2019 | Details |
| A10521 | 31304450 | Hepatol Commun | Selective Liver Estrogen Receptor α Modulation Prevents Steatosis, Diabetes, and Obesity Through the Anorectic Growth Differentiation Factor 15 Hepatokine in Mice. | 2019 | Details |
| A10525 | 31301321 | J Hepatol | Crosstalk between adipose tissue insulin resistance and liver macrophages in non-alcoholic fatty liver disease. | 2019 | Details |
| A10526 | 31301251 | Clin Endocrinol (Oxf) | Clinical prediction score of nonalcoholic fatty liver disease in adolescent girls with polycystic ovary syndrome (PCOS-HS index). | 2019 | Details |
| A10535 | 31298151 | Curr Pharm Des | Obesity, Metabolic Syndrome and the Risk of Microvascular Complications in Patients with Diabetes mellitus. | 2019 | Details |
| A10540 | 31293912 | J Clin Transl Hepatol | Practical Use of Transient Elastography in Screening for Nonalcoholic Steatohepatitis in a Japanese Population. | 2019 | Details |
| A10545 | 31293441 | Front Physiol | The Influence of Different Fat Sources on Steatohepatitis and Fibrosis Development in the Western Diet Mouse Model of Non-alcoholic Steatohepatitis (NASH). | 2019 | Details |
| A10549 | 31293021 | Phytother Res | The effects of black seed supplementation on cardiovascular risk factors in patients with nonalcoholic fatty liver disease: A randomized, double-blind, placebo-controlled clinical trial. | 2019 | Details |
| A10551 | 31292564 | Nat Rev Rheumatol | Cardiometabolic comorbidities in RA and PsA: lessons learned and future directions. | 2019 | Details |
| A10570 | 31284753 | FASEB J | Hepatic PEMT activity mediates liver health, weight gain, and insulin resistance. | 2019 | Details |
| A10571 | 31284538 | Molecules | The Modulatory Action of Vitamin D on the Renin-Angiotensin System and the Determination of Hepatic Insulin Resistance. | 2019 | Details |
| A10580 | 31281460 | Exp Ther Med | Aged garlic extract ameliorates fatty liver and insulin resistance and improves the gut microbiota profile in a mouse model of insulin resistance. | 2019 | Details |
| A10588 | 31279902 | J Hepatol | The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: A systematic review and meta-analysis. | 2019 | Details |
| A10591 | 31278754 | J Physiol | Liver sympathetic denervation reverses obesity-induced hepatic steatosis. | 2019 | Details |
| A10599 | 31275421 | Evid Based Complement Alternat Med | The Combination of Mulberry Extracts and Silk Amino Acids Alleviated High Fat Diet-Induced Nonalcoholic Hepatic Steatosis by Improving Hepatic Insulin Signaling and Normalizing Gut Microbiome Dysbiosis in Rats. | 2019 | Details |
| A10601 | 31275407 | Evid Based Complement Alternat Med | Pharmacological Activities of Alisma orientale against Nonalcoholic Fatty Liver Disease and Metabolic Syndrome: Literature Review. | 2019 | Details |
| A10602 | 31275240 | Front Endocrinol (Lausanne) | Transient Elastography and Controlled Attenuation Parameter (CAP) in the Assessment of Liver Steatosis in Severe Adult Growth Hormone Deficiency. | 2019 | Details |
| A10611 | 31272028 | J Nutr Biochem | 1-Deoxynojirimycin improves high fat diet-induced nonalcoholic steatohepatitis by restoring gut dysbiosis. | 2019 | Details |
| A10614 | 31271251 | Mol Nutr Food Res | Diet Consisting of Balanced Yogurt, Fruit, and Vegetables Modifies the Gut Microbiota and Protects Mice against Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A10621 | 31267355 | J Nat Med | Consumption of lycopene-rich tomatoes improved glucose homeostasis in rats via an increase in leptin levels. | 2019 | Details |
| A10624 | 31266632 | Biochem Biophys Res Commun | Expression of Vsig4 attenuates macrophage-mediated hepatic inflammation and fibrosis in high fat diet (HFD)-induced mice. | 2019 | Details |
| A10628 | 31264313 | Phytother Res | Hesperidin improves hepatic steatosis, hepatic enzymes, and metabolic and inflammatory parameters in patients with nonalcoholic fatty liver disease: A randomized, placebo-controlled, double-blind clinical trial. | 2019 | Details |
| A10642 | 31257745 | Endocrinol Metab (Seoul) | Triglyceride Glucose Index Is Superior to the Homeostasis Model Assessment of Insulin Resistance for Predicting Nonalcoholic Fatty Liver Disease in Korean Adults. | 2019 | Details |
| A10651 | 31254236 | Clin Rheumatol | Metabolic syndrome, non-alcoholic fatty liver disease and liver stiffness in psoriatic arthritis and psoriasis patients. | 2019 | Details |
| A10653 | 31252266 | Biomed Pharmacother | Gender effect of hyperuricemia on the development of nonalcoholic fatty liver disease (NAFLD): A clinical analysis and mechanistic study. | 2019 | Details |
| A10658 | 31251092 | Curr Med Res Opin | Phenotypic characteristics and risk factors in a multi-ethnic cohort of young adults with type 2 diabetes. | 2019 | Details |
| A10659 | 31250564 | Physiol Rep | AdipoRon prevents myostatin-induced upregulation of fatty acid synthesis and downregulation of insulin activity in a mouse hepatocyte line. | 2019 | Details |
| A10663 | 31246081 | Eur J Paediatr Dent | The sweet danger of added sugars. | 2019 | Details |
| A10664 | 31245932 | Obesity (Silver Spring) | Association Between Nonalcoholic Fatty Liver Disease and Future Deterioration of Metabolic Health: A Cohort Study. | 2019 | Details |
| A10670 | 31244307 | Asian Pac J Cancer Prev | Significance of Serum Adiponectin and Insulin Resistance Levels in Diagnosis of Egyptian Patients with Chronic Liver Disease and HCC. | 2019 | Details |
| A10672 | 31243652 | Endocrine | Insulin-like growth factor-1 and non-alcoholic fatty liver disease: a systemic review and meta-analysis. | 2019 | Details |
| A10684 | 31236937 | Australas J Dermatol | Nonalcoholic fatty liver disease puts patients with psoriasis at greater cardiovascular risk. | 2019 | Details |
| A10686 | 31236687 | Handb Exp Pharmacol | Potential of Intestine-Selective FXR Modulation for Treatment of Metabolic Disease. | 2019 | Details |
| A10688 | 31235168 | Diabetes Metab Syndr | Efficacy of a non-invasive model in predicting the cardiovascular morbidity and histological severity in non-alcoholic fatty liver disease. | 2019 | Details |
| A10689 | 31235166 | Diabetes Metab Syndr | A narrative review on effects of vitamin D on main risk factors and severity of Non-Alcoholic Fatty Liver Disease. | 2019 | Details |
| A10691 | 31235092 | Diabetes Metab Syndr | Study of relationship between total vitamin D level and NAFLD in a sample of Egyptian patients with and without T2DM. | 2019 | Details |
| A10695 | 31233775 | J Control Release | The hepatic-targeted, resveratrol loaded nanoparticles for relief of high fat diet-induced nonalcoholic fatty liver disease. | 2019 | Details |
| A10698 | 31233523 | PLoS One | Apical sodium-dependent bile acid transporter inhibition with volixibat improves metabolic aspects and components of non-alcoholic steatohepatitis in Ldlr-/-.Leiden mice. | 2019 | Details |
| A10712 | 31226399 | Free Radic Biol Med | Berberine attenuates nonalcoholic hepatic steatosis through the AMPK-SREBP-1c-SCD1 pathway. | 2019 | Details |
| A10713 | 31226232 | Liver Int | Metabolically healthy versus unhealthy obesity and risk of fibrosis progression in non-alcoholic fatty liver disease. | 2019 | Details |
| A10717 | 31225483 | Cell Stress | Foie gras and liver regeneration: a fat dilemma. | 2018 | Details |
| A10719 | 31223344 | Diabetol Metab Syndr | Insulin resistance exhibits varied metabolic abnormalities in nonalcoholic fatty liver disease, chronic hepatitis B and the combination of the two: a cross-sectional study. | 2019 | Details |
| A10720 | 31222979 | J Cell Mol Med | Hepatic functional and pathological changes of type 1 diabetic mice in growing and maturation time. | 2019 | Details |
| A10728 | 31219486 | Saudi Med J | Position statement on the diagnosis and management of non-alcoholic fatty liver disease. | 2019 | Details |
| A10729 | 31219362 | Infect Dis (Lond) | Improvement in liver steatosis after the switch from a ritonavir-boosted protease inhibitor to raltegravir in HIV-infected patients with non-alcoholic fatty liver disease. | 2019 | Details |
| A10734 | 31216433 | J Ethnopharmacol | Exploring the protective effect of ShengMai-Yin and Ganmaidazao decoction combination against type 2 diabetes mellitus with nonalcoholic fatty liver disease by network pharmacology and validation in KKAy mice. | 2019 | Details |
| A10735 | 31216264 | J Pediatr Endocrinol Metab | Genetic polymorphisms associated with obesity and non-alcoholic fatty liver disease in Asian Indian adolescents. | 2019 | Details |
| A10737 | 31215394 | Mol Med | FBXW7 suppresses HMGB1-mediated innate immune signaling to attenuate hepatic inflammation and insulin resistance in a mouse model of nonalcoholic fatty liver disease. | 2019 | Details |
| A10744 | 31213868 | Diabetes Metab Syndr Obes | The negative and detrimental effects of high fructose on the liver, with special reference to metabolic disorders. | 2019 | Details |
| A10761 | 31206703 | J Physiol | Anti-inflammatory effects of oestrogen mediate the sexual dimorphic response to lipid-induced insulin resistance. | 2019 | Details |
| A10763 | 31204416 | J Gastrointestin Liver Dis | Effect of Phytosomal Curcumin on Circulating Levels of Adiponectin and Leptin in Patients with Non-Alcoholic Fatty Liver Disease: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial. | 2019 | Details |
| A10768 | 31203554 | Dig Dis Sci | Efficacy of Probiotics and Synbiotics in Patients with Nonalcoholic Fatty Liver Disease: A Meta-Analysis. | 2019 | Details |
| A10769 | 31202833 | Metabolism | Effects of dapagliflozin and/or insulin glargine on beta cell mass and hepatic steatosis in db/db mice. | 2019 | Details |
| A10775 | 31197983 | J Korean Med Sci | Usefulness of Transient Elastography for Non-Invasive Diagnosis of Liver Fibrosis in Pediatric Non-Alcoholic Steatohepatitis. | 2019 | Details |
| A10777 | 31197470 | Acta Diabetol | Risk factors for non-alcoholic fatty liver disease-associated hepatic fibrosis in type 2 diabetes patients. | 2019 | Details |
| A10779 | 31197160 | Cell Death Dis | Berberine promotes the recruitment and activation of brown adipose tissue in mice and humans. | 2019 | Details |